1.An extremely rare elderly case of proximal epithelioid sarcoma of the vulva: case report with a review of literatures
Si Eun JEON ; Jina LEE ; Hee Jung JUNG ; Beob-Jong KIM ; Sang-Young RYU ; Sang-Il PARK ; Hye-Sil SEOL ; Won-Il JANG ; Moon-Hong KIM
Obstetrics & Gynecology Science 2020;63(5):670-674
We experienced an extremely rare case of proximal epithelioid sarcoma (PES) of the vulva in a 77-year-old woman. After history taking and physical examination, the patient was tentatively diagnosed as having Bartholin’s cyst in the right labium. Based on histopathological and immunohistochemical (IHC) findings, however, a final diagnosis of PES of the vulva was made. After receiving CyberKnife treatment, the patient survived but with recurrent episodes and poor prognosis. In conclusion, our case indicates that patients with PES of the vulva should be appropriately managed with radiotherapy after a differential diagnosis based on histopathological and IHC findings.
2.An extremely rare elderly case of proximal epithelioid sarcoma of the vulva: case report with a review of literatures
Si Eun JEON ; Jina LEE ; Hee Jung JUNG ; Beob-Jong KIM ; Sang-Young RYU ; Sang-Il PARK ; Hye-Sil SEOL ; Won-Il JANG ; Moon-Hong KIM
Obstetrics & Gynecology Science 2020;63(5):670-674
We experienced an extremely rare case of proximal epithelioid sarcoma (PES) of the vulva in a 77-year-old woman. After history taking and physical examination, the patient was tentatively diagnosed as having Bartholin’s cyst in the right labium. Based on histopathological and immunohistochemical (IHC) findings, however, a final diagnosis of PES of the vulva was made. After receiving CyberKnife treatment, the patient survived but with recurrent episodes and poor prognosis. In conclusion, our case indicates that patients with PES of the vulva should be appropriately managed with radiotherapy after a differential diagnosis based on histopathological and IHC findings.
3.Prognostic significance of pretreatment lymphocyte percentage and age at diagnosis in patients with locally advanced cervical cancer treated with definite radiotherapy.
Myung Hwa JEONG ; Hyungjoo KIM ; Tae Hun KIM ; Moon Hong KIM ; Beob Jong KIM ; Sang Young RYU
Obstetrics & Gynecology Science 2019;62(1):35-45
OBJECTIVE: This study aimed to evaluate the prognostic impact of age at diagnosis, and pretreatment hematologic markers, including lymphocyte percentage and the neutrophil-to-lymphocyte ratio (NLR), in patients with locally advanced cervical cancer (LACC) treated with definitive radiotherapy (RT). METHODS: A total of 392 patients with LACC (stage IIb to IVa) treated with cisplatin-based concurrent chemoradiotherapy or RT alone between 2001 and 2012 were retrospectively enrolled. Clinical data and pretreatment complete blood counts were extracted from electronic medical records of the patients, and analyzed. Treatment outcomes, progression-free survival (PFS), and overall survival (OS) were evaluated. RESULTS: Low lymphocyte percentage and a high NLR were associated with younger age, advanced stage, larger tumor size, lymph nodes metastasis, and treatment failure. The cut-off value for lymphocyte percentage and NLR was determined using a receiver operating characteristic curve. In univariate analysis, low lymphocyte percentage (≤24%) was associated with poor PFS and OS, while high NLR ( > 2.8) was significantly associated only with PFS. In multivariate analysis, both lymphocyte percentage (hazard ratio [HR], 0.59; 95% confidence interval [CI], 0.40–0.85; P=0.005) and NLR (HR, 1.55; 95% CI, 1.07–2.25; P=0.022) had independent prognostic value for PFS. Compared to younger patients (age ≤50 years), older patients (age > 60 years) had a lower risk of death. CONCLUSION: Although the lymphocyte percentage did not remain significant in multivariate analysis for OS, it was predictive of PFS and OS. Thus, lymphocyte percentage is a simple hematologic parameter with a significant prognostic value in patients with LACC treated with definitive RT.
Aging
;
Blood Cell Count
;
Chemoradiotherapy
;
Diagnosis*
;
Disease-Free Survival
;
Electronic Health Records
;
Hematologic Tests
;
Humans
;
Lymph Nodes
;
Lymphocytes*
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Prognosis
;
Radiotherapy*
;
Retrospective Studies
;
ROC Curve
;
Treatment Failure
;
Uterine Cervical Neoplasms*
4.Characteristics of thyroid incidentalomas detected by pre-treatment 18FFDG PET or PET/CT in patients with cervical cancer.
Won Moo LEE ; Beob Jong KIM ; Moon Hong KIM ; Seok Cheol CHOI ; Sang Young RYU ; Ilhan LIM ; Kidong KIM
Journal of Gynecologic Oncology 2012;23(1):43-47
OBJECTIVE: Considering the increased use of [18F]FDG PET or PET/CT, the clinical significance of thyroid incidentalomas is the subject of controversy. The aim of this study was to determine the incidence of malignancies associated with thyroid incidentalomas detected by pre-treatment PET or PET/CT in patients with cervical cancer. METHODS: We retrospectively reviewed the medical records of patients with cervical cancer who had thyroid incidentalomas detected by pre-treatment PET or PET/CT and were treated at our institute between January 2001 and December 2009. RESULTS: Of 327 patients who underwent pre-treatment PET or PET/CT, 33 patients had thyroid incidentalomas (10.1%) and 4 patients were diagnosed with thyroid malignancies by percutaneous needle aspiration (PCNA) or surgery. To put it concretely, of 33 patients with thyroid incidentaloma, 16 patients had a diffuse uptake and 17 patients had a focal uptake. Four of 17 patients with focal uptake were diagnosed with thyroid malignancies (23.5%). One patient with a focal uptake had an atypical cell based on PCNA, but did not undergo additional studies. The mean SUVmax of thyroid malignancies did not differ from that of benign thyroid diseases. CONCLUSION: Thyroid incidentalomas are frequently detected by pre-treatment PET or PET/CT in patients with cervical cancer. Focal uptake on PET or PET/CT has a high risk of thyroid cancer.
Fluorodeoxyglucose F18
;
Humans
;
Incidence
;
Medical Records
;
Needles
;
Positron-Emission Tomography
;
Positron-Emission Tomography and Computed Tomography
;
Proliferating Cell Nuclear Antigen
;
Retrospective Studies
;
Thyroid Gland
;
Thyroid Neoplasms
;
Uterine Cervical Neoplasms
5.Discharge criteria should be validated in patients who undergo ambulatory gynecologic surgery.
Kidong KIM ; Beob Jong KIM ; Moon Hong KIM ; Seok Cheol CHOI ; Sang Young RYU
Journal of Gynecologic Oncology 2011;22(2):140-141
No abstract available.
Female
;
Gynecologic Surgical Procedures
;
Humans
6.Guideline adherence to chemotherapy administration safety standards: a survey on nurses in a single institute.
Kidong KIM ; Hee Sook LEE ; Younha KIM ; Beob Jong KIM ; Moon Hong KIM ; Seok Cheol CHOI ; Sang Young RYU
Journal of Gynecologic Oncology 2011;22(1):49-52
OBJECTIVE: Little is known about the guideline adherence of nurses to chemotherapy administration guidelines. We determined the guideline adherence of nurses to the Chemotherapy Administration Safety Standards and the relationship between demographic characteristics and guideline adherence. METHODS: Survey sheets containing two questions on demographic characteristics and 16 questions on the guideline adherence of nurses regarding chemotherapy administration were distributed to all in-patient departments in our hospital in which chemotherapy was performed. All clinical nurses in the department were recommended to respond. RESULTS: Of 202 nurses, 123 responses were collected (61% response rate). The guideline adherence rate was >70% for 15 of 16 questions, but 55% of respondents indicated that there was no competency monitoring for nurses. Nurses with >7 years of clinical nursing experience felt more competent in performing cardiopulmonary resuscitation (CPR) than nurses with <7 years of clinical nursing experience (p=0.032). CONCLUSION: The guideline adherence rate of nurses with respect to chemotherapy administration was high, with the exception of the absence of a competency monitoring for nurses. A significant number of nurses with <7 years of clinical nursing experience felt incompetent in performing CPR.
Cardiopulmonary Resuscitation
;
Guideline Adherence
;
Surveys and Questionnaires
7.Detection of Recurrence by 18F-FDG PET in Patients with Endometrial Cancer Showing No Evidence of Disease.
Sang Young RYU ; Kidong KIM ; Younha KIM ; Sang Il PARK ; Beob Jong KIM ; Moon Hong KIM ; Seok Cheol CHOI ; Eui Don LEE ; Kyung Hee LEE ; Byung Il KIM
Journal of Korean Medical Science 2010;25(7):1029-1033
This study assessed the feasibility of F-18-fluorodeoxyglucose positron-emission tomography (18F-FDG PET) in the post-therapy surveillance for patients with endometrial cancer showing no evidence of disease (NED). From April 1997 to June 2007, 127 patients with endometrial cancer showing NED were performed 18F-FDG PET scan. The feasibility of 18F-FDG PET for the early detection of recurrence in patients with endometrial cancer was evaluated retrospectively. Of the 127 patients, 32 patients showed positive lesions on 18F-FDG PET scan. Nineteen (19/127 cases, 15%) of them were confirmed to have a recurrence clinically or histologically. The sensitivity, specificity and positive and negative predictive value of 18F-FDG PET for detecting recurrences in patients with endometrial cancer were 100%, 88%, 59% and 100%, respectively. In conclusion, 18F-FDG PET may be a useful method for the post-therapy surveillance in patients with endometrial cancer.
Adult
;
Aged
;
Endometrial Neoplasms/*diagnosis/pathology/*radionuclide imaging
;
Female
;
Fluorodeoxyglucose F18/*diagnostic use
;
Humans
;
Middle Aged
;
Neoplasm Recurrence, Local/*diagnosis/pathology/*radionuclide imaging
;
Positron-Emission Tomography/*methods
;
Predictive Value of Tests
;
Retrospective Studies
;
Sensitivity and Specificity
8.The type of metastasis is a prognostic factor in disseminated cervical cancer.
Kidong KIM ; Soo Youn CHO ; Beob Jong KIM ; Moon Hong KIM ; Seok Cheol CHOI ; Sang Young RYU
Journal of Gynecologic Oncology 2010;21(3):186-190
OBJECTIVE: The objectives of this study were twofold: to verify whether the type of metastasis (lymphatic vs. hematogenous) is a prognostic factor, and to identify molecular markers associated with survival in patients with disseminated cervical cancer. METHODS: Between April 1997 and May 2008, 30 patients with disseminated cervical cancer who had supraclavicular lymph node (N=13) or hematogenous metastases (N=17) were initially treated at our institute. We reviewed medical records to extract clinicopathologic variables. For 17 patients with available pathological specimens, we evaluated the association of immunohistochemical staining for metalloproteinase (MMP)-2, vascular endothelial growth factor (VEGF)-A, and laminin V gamma (LAMC)-2 with survival and clinicopathologic variables via a log-rank test and Cox regression analysis. RESULTS: Patients who had only lymphatic metastasis (odds ratio [OR], 5.3; 95% confidence interval [CI], 1.4 to 19.5) or completed initial treatment (OR, 3.2; 95% CI, 1.1 to 9.9) showed better survival than patients who did not, but none of the molecular markers were associated with survival. Out of 13 patients with only lymphatic metastasis, three patients who had received volume-directed radiation with concurrent chemotherapy had a long-term survival of over two years. However, patients with hematogenous metastasis showed extremely poor prognosis. CONCLUSION: The type of metastasis and completion of initial treatment were associated with prolonged survival in patients with disseminated cervical cancer, and over 20% of patients with lymphatic metastasis were salvaged with volume-directed radiation with concurrent chemotherapy. None of the molecular markers were associated with survival in patients with disseminated cervical cancer.
Humans
;
Laminin
;
Lymph Nodes
;
Lymphatic Metastasis
;
Medical Records
;
Neoplasm Metastasis
;
Prognosis
;
Uterine Cervical Neoplasms
;
Vascular Endothelial Growth Factor A
9.Clinicopathologic characteristics and prognostic factors of primary peritoneal carcinoma.
Hee Joung WOO ; Sang Heon KIM ; Kidong KIM ; Sang Il PARK ; Yong Jung SONG ; Beob Jong KIM ; Moon Hong KIM ; Seok Cheol CHOI ; Sang Young RYU ; Eui Don LEE ; Kyung Hee LEE
Korean Journal of Obstetrics and Gynecology 2009;52(2):212-219
OBJECTIVE: The objective of this study was to examine the clinicopathologic characteristics and prognostic factors of primary peritoneal carcinoma (PPC). METHODS: Clinicopathologic variables were obtained by examining the medical records of patients with PPC who were diagnosed and treated at our institute, between January 1996 and December 2005. To find prognostic factors, the association of clinicopathologic variables with survival was evaluated by univariate and multivariate analysis. RESULTS: All patients had advanced-stage tumors. Residual tumor was smaller than 1 cm in 12 patients and was equal or larger than 1 cm in nine patients. The response rate to adjuvant chemotherapy was 47.6%. The median progression-free survival was eight months (range 1~95) and the median overall survival was 14 months (range 1~99). In univariate analysis, stage, the response to adjuvant chemotherapy, and neoadjuvant chemotherapy were associated with survival. However, in multivariate analysis, no variables were associated with survival. CONCLUSION: In spite of aggressive treatments, patients with PPC had poor prognosis. No prognostic factors were identified in this study.
Chemotherapy, Adjuvant
;
Disease-Free Survival
;
Humans
;
Medical Records
;
Multivariate Analysis
;
Neoplasm, Residual
;
Prognosis
10.A case of ovarian metastasis on transposed ovary in patient treated for uterine cervical cancer.
Sang Heon KIM ; Do Young KWON ; Yu Suk YU ; Beob Jong KIM ; Moon Hong KIM ; Seok Chul CHOI ; Sang Young RYU
Korean Journal of Obstetrics and Gynecology 2009;52(9):955-959
In case of young women treated with ovarian preservation in cervical cancer surgery, it is regarded pertinent to reduce the risk of early menopause resulting from adjuvant pelvic irradiation through ovarian transposition. On the other hand, lots of authors have raised questions in regard with the ovary being possibly affected by micrometastasis. Studies have reported appropriate indications of ovarian transposition and risk factors of ovarian metastasis to cope with this problem. We conducted ovarian transposition with cervical cancer patient who had no ovarian metastasis risk factors reported in previous literature and experienced such case that metastasis took place only in the ovary without spreading to other organs. This study is to report that case based on brief literature review.
Female
;
Hand
;
Humans
;
Hypogonadism
;
Menopause
;
Mitochondrial Diseases
;
Neoplasm Metastasis
;
Neoplasm Micrometastasis
;
Ophthalmoplegia
;
Ovary
;
Phosphatidylethanolamines
;
Risk Factors
;
Uterine Cervical Neoplasms

Result Analysis
Print
Save
E-mail